Class IIITerminatedD-0244-2021
Drug recall · February 3, 2021
Phytonadione Tablets 5mg recall
Why: Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA NDC 68682-170-30
- Lots / codes
Lot: 18L091P, Exp 05/2021
- Quantity
- 14,089 bottles
- Company
- Bausch Health Companies, Inc., Bridgewater, NJ
- Distribution
- Distributed Nationwide in the USA
- Initiated
- January 7, 2021 · Voluntary: Firm initiated
- Classified
- January 25, 2021
- Reported
- February 3, 2021
- Ended
- February 11, 2022
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.